Limitations of RECIST guidelines Srinivasa R Prasad MD Associate Professor, Radiology University of Texas Health Science Center at San Antonio.

Slides:



Advertisements
Similar presentations
Michael L. Parchman, MD1 Amer Kassai, PhD2 Jacqueline A. Pugh, MD1
Advertisements

CLINICAL USE OF SPECT-CT IN BREAST & PROSTATE CANCERS
Accenture Life Sciences Rethink Reshape Restructure… for better patient outcomes CDISC Journey in Lymphoma using Cheson 2007 Kevin Lee CDISC NJ meeting.
Sandra G. Adams, MD, MS Pulmonary Diseases / Critical Care Medicine University of Texas Health Science Center at San Antonio South Texas Veterans Healthcare.
Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
CT Findings in Pulmonary Tuberculosis
Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J
A Proposal for BMS (Dasatinib) in GIST Jon Trent, MD, PhD Assistant Professor Dept. of Sarcoma Medical Oncology The University of Texas, M. D. Anderson.
ACRIN 6673 MULTICENTER FEASIBILITY STUDY OF PERCUTANEOUS RADIOFREQUENCY ABLATION OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS Final Report from Central.
Volumetric Measurement of Tumors David F. Yankelevitz, MD.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
Radiology of Thyroid and parathyroid
Early Experience of a Commercial Available Robot (Maxio) for CT-guided Radiofrequency Ablation of liver tumours 1 BJJ Abdullah, 1 CH Yeong, 2 KL Goh, 3.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
Taylor J Greenwood, MD, Adam Wallace, MD, Aseem Sharma, MD, Jack Jennings, MD, PhD.
Brain tumor analysis By: Ninad Mehendale.
Treatment Planning Optimization for Radiofrequency Ablation of Hepatic Tumors Hernán Abeledo, Ph.D. Associate Professor Engineering Management and Systems.
Response Evaluation of Gastrointestinal Stromal Tumors (GIST)
The Role of Imaging in Sinusitis Dr Mohamed El Safwany, MD.
Tumor Localization Techniques Richard Kao April 10, 2001 Computer Integrated Surgery II.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
Update on Lung Cancer Image Processing Rick Avila Karthik Krishnan Luis Ibanez Kitware, Inc. April 19, 2006.
ACRIN 6673 Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients: A Multi-Center Study.
1 R2 ImageChecker CT CAD PMA: Clinical Results Nicholas Petrick, Ph.D. Office of Science and Technology Center for Devices and Radiological Health U.S.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
COMBI RECIST 1.1 February Target Lesions: Selection at Baseline Perform baseline evaluations as close to treatment start as possible (no more than.
RECIST Overview.
Anatomic and Functional Imaging Evaluation of a Clinical Trial of an IGFR Antibody in Patients (PTS) with Ewing Sarcoma (ES) Vadim Koshkin; Vanessa Bolejack;
The clinical role of PET scanning in GIST Seattle 2007 The clinical role of PET scanning in a consecutive series of GIST patients Department of Surgery.
Andrew W. Asimos, MD How Can We Use Advanced Neuroimaging in the ED to Optimize Treatment Options for Acute Stroke Patients?
Percutaneous Cryoablation for Renal Cell Cancer Christos Georgiades MD PhD Assistant Professor of Radiology & Surgery Vascular & Interventional Radiology.
NYU Medicine Grand Rounds Clinical Vignette David Altszuler, MD PGY-2 December 11, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Target: Treatment and Review.  Why do we consider some symptoms of schizophrenia “positive”?  What are some positive symptoms?  Take out your reference.
Medical Image SBIA.UPenn Christos Davatzikos Director, Section of Biomedical Image Analysis Professor, Radiology,
OPTN Liver and Intestinal Organ Transplantation Committee Update Spring 2012 Kim Olthoff, MD, Chair David Mulligan, MD, Vice-chair.
Evaluation of metastatic brain lesions by intraoperative ultrasonography (IOUS) Mehdi Abouzari and Mehdi Abdollahzadeh Dr. Shariati Hospital, Tehran University.
Lung shadows.
1 A continued FDA Concern about Imaging Based Drug Trials Society of Nuclear Medicine Albuquerque, Feb 1-2, 2009 Orhan H Suleiman MS PhD, FAAPM Senior.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Selumetinib vs Chemotherapy on Progression-Free.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Everolimus for Advanced Pancreatic Neuroendocrine Tumors N Engl J Med 2011;364: R4. 박선희 / Prof. 동석호.
Conventional Tomography :. Conventional Tomography Performed when there is overlap of bony or soft tissue structures at the area of interest, Multiple.
Choosing Wisely : Radiology Perspective
Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer Respiration 2015;90: DOI: /
Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients1   Tatsuya Nishida, MD, Kiyotoshi Inoue,
Treatment of Oligometatic PNET Mets to Liver Following Resection
Microwave Ablation of a Bosniak III Renal Cyst
7.3c. Post-Contrast Axial CT of the Brain
COLORECTAL LIVER METASTASES:
Audit Update LUNG-MAP Rose Ermete, Rn, bsn, ocn, ccrp
Two lesions are seen within the lateral segment of the left lobe of the liver (yellow arrows). They appear mildly hyperintense on T2 images and mildly.
Applications of Diagnostic Imaging Nuclear Medicine
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets Case Rep Oncol 2016;9:
Nontuberculous Mycobacterial Lung Disease
Avinash Kambadakone Ramesh1
Future of Thoracic PET Scanning
The Role of Modern Molecular Imaging Techniques in Gastroenterology
Emergence of resistance to immune checkpoint blockade is associated with elimination of mutation-associated neoantigens by LOH and a more diverse T-cell.
Andrew Wright MD, Chris Johnson, Fred Lee Jr. MD, and David Mahvi MD
Future of Thoracic PET Scanning
Fig. 5. Clinical data with BLU-285 confirm early evidence of activity in patients with diseases driven by KIT and PDGFRA activation loop mutations. Clinical.
A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria  Anne S. Tsao,
Clinical courses of patients.
(A) Survival time. (A) Survival time. All patients. (a) PFS since the start of EGFR-TKI (groups A, B and C). (b) OS since the start of EGFR-TKI (groups.
Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after.
Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD 
General strategies of Cancer Treatment and evaluation of Response
Pre-K Classes in San Antonio | Pre-K San Antonio | Discovery World Learning Center
Antitumor activity. Antitumor activity. A, maximum change in target lesion size from baseline assessed according to RECIST 1.0 (n = 26). Six patients had.
A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.
Presentation transcript:

Limitations of RECIST guidelines Srinivasa R Prasad MD Associate Professor, Radiology University of Texas Health Science Center at San Antonio

RECIST Guidelines Response Evaluation Criteria In Solid Tumors Assumes spherical growth of round / ovoid tumors Uni-dimensional measurement technique –Less cumbersome, Simple math Arbitrary number of measurable lesions –5/organ; 10/patient

Target lesions: >1cm (Helical); >2cm (Non-helical) Measurement on axial images Increase in the threshold for classifying response as disease progression Primary modality: CT scan RECIST Guidelines

Limitations of RECIST guidelines No criteria for non-solid tumors No toxicity criteria Lower rate of disease progression? Not applicable to Non-Cytotoxic drugs?

Change in Tumor Form: From Solid to Non-Solid

Tumor morphology –Confluent, Irregular borders –Unusual configuration; Circumferential (eg. mesothelioma) –Lesion length > times lesion width Discordant results due to RECIST technique –Uni-dimensional measurement –Shape changes may confound results Limitations of RECIST guidelines

Lesion Confluence and Relationship to Normal Anatomical Structures

Unusual Lesion Configuration

Lesion Morphology: Mesothelioma

Non-spherical, asymmetric tumor growth Tumor size: Sub-centimeter tumors Choosing representative tumor burden –Problematic when tumor burden is substantial –Differential tumor response Limitations of RECIST guidelines

Differential tumor behavior Pre Post

Discordant results due to RECIST technique –Unusual Tumor morphology Confluent tumors, Unusual growth pattern Lesion length > 2 times lesion width Lesions with irregular / infiltrative borders –Unpredictable Tumor Behavior Differential tumor shrinkage/growth Limitations of RECIST guidelines

Differential tumor behavior

Change in Tumor Form: From Solid to Non-Solid

Updated imaging technology not considered –Multiplanar capability –Automated tumor detection –3-D data acquisition: volumetric tumor measurement Limitations of RECIST guidelines

Criteria for tumors treated by Non-drugs? (eg: Radio-frequency ablation) Metabolic and physiological changes predate tumor size change Limitations of RECIST guidelines

Non-Drug treatment of tumors: Response criteria?

Imaging Pitfalls: Scanning & Visualization Techniques

Future? WHO-Bidimensional RECIST-Unidimensional Volumetric